LITT
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LITT, covering 2022-12-23 to 2022-12-23. Get the full timeline:
Most recent: Clinical Trial Update: LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas [Phase 1, Phase 2]